EMERGING APPLICATIONS OF THE SINGLE-CELL GEL-ELECTROPHORESIS (COMET) ASSAY - I - MANAGEMENT OF INVASIVE TRANSITIONAL-CELL HUMAN BLADDER-CARCINOMA - II - FLUORESCENT IN-SITU HYBRIDIZATION COMETS FOR THE IDENTIFICATION OF DAMAGED AND REPAIRED DNA-SEQUENCES IN INDIVIDUAL CELLS
Vj. Mckelveymartin et al., EMERGING APPLICATIONS OF THE SINGLE-CELL GEL-ELECTROPHORESIS (COMET) ASSAY - I - MANAGEMENT OF INVASIVE TRANSITIONAL-CELL HUMAN BLADDER-CARCINOMA - II - FLUORESCENT IN-SITU HYBRIDIZATION COMETS FOR THE IDENTIFICATION OF DAMAGED AND REPAIRED DNA-SEQUENCES IN INDIVIDUAL CELLS, Mutagenesis, 13(1), 1998, pp. 1-8
I. Management of invasive transitional human bladder carcinoma. The tw
o main treatment options for invasive transitional cell bladder carcin
oma are radiotherapy or primary cystectomy with urinary diversion or b
ladder substitution. Approximately 50% of patients fail to respond to
radiotherapy and such patients so treated are disadvantaged by the abs
ence of predictive information regarding their radiosensitivity, since
the tumour gains additional time for metastic spread before cystectom
y is performed. The SF2 clonogenic assay, which measures the surviving
fraction of tumour cells after 2 Gy X-ray irradiation, is regarded as
a good measure of radiosensitivity. However, the assay is time consum
ing and provides results for only approximately 70% of human tumours.
In this paper three bladder transitional cell carcinoma cell line (HT1
376, UMUC-3 and RT112) were exposed to X-irradiation (0-10 GY). We hav
e compared the responses obtained using a clonogenic assay and a more
clinically feasible alkaline single cell gel electrophoresis (Comet) a
ssay. A very good inverse correlation was obtained between cell surviv
al (clonogenic assay) and mean tail moment (Comet assay) for the three
cell lines, indicating that the Comet assay can be used to predict th
e radio-responsiveness of individual cell lines. The clinical usefulne
ss of the assay for predicting response to radiotherapy in bladder can
cer patients is currently being investigated. II. Fluorescent in situ
hybridization (FISH) Comets for the identification of damaged and repa
ired DNA sequences in individual cells. In mammalian cells the extent
of DNA damage is partly and the rate of DNA repair very considerably d
ependent on DNA position and transcription. This has been established
by biochemical techniques which are labour intensive and require large
numbers of cells. The Comet assay for overall DNA damage and repair i
s relatively simple and allows individual cells to be examined. Here w
e present a protocol for combination of the Comet assay with fluoresce
nt in situ hybridization (FISH) using a p53 sequences with DNA comets.
Chromosome-specific probes can also be used. Optimization of the FISH
/Comet protocol to include automation of the analysis is currently und
erway to facilitate future application of the technique to study selec
tive DNA damage and repair in defined sequences in single mammalian ce
lls.